Common Adverse Drug Reactions in Primary Care
- Registration Closed
This presentation will cover the prevalence and types of adverse drug reactions in patients taking medications prescribed in the outpatient setting. We will review case studies and discuss prevention and treatment of unexpected side effects in the primary care setting.
Credits: 1.50 contact hours; 1.50 are pharmacology
Expiration Date: December 31, 2024
$40.00
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-Name 3 drugs associated with common adverse reactions in primary care
-Name 3 of the most common types of adverse drug reactions (ADR) in primary care
-Name 3 methods of avoiding/minimizing common drug reactions in primary care
Phyllis Everett, MSN, RN, AOCN, AGN-BC, NP-C
Executive Director/Adult Nurse Practitioner
Sapient Health Services, PLLC
Phyllis is a nurse practitioner certified in adult primary care, oncology and genetics with a sub-specialty certification in pharmacogenetics. She is owner and adult nurse practitioner at Sapient Health Services and has served in rural VA since September 2017.
She received a diploma RN at Norfolk General Hospital School of Professional Nursing in 1979, a BS in Nursing with a Minor in Psychology at UNC-Greensboro in 1983 and her MS in Nursing Administration also at UNC-G in 1988.
She earned two post-masters certificates at Duke, Nursing Informatics in 1997 and Adult Nurse Practitioner with a focus in Primary Care/Oncology in 2005.
Phyllis is published, and her original research has been presented in poster presentations at the national and state level. She is a speaker on a variety of topics related to her practice and certifications and has been invited to present at multiple venues around the country.
Phyllis was president of the Virginia Council of Nurse Practitioners (VCNP) from 2012-2014 and was awarded the Distinguished NP Award at the VCNP annual meeting in March 2016.
Sapient Health Services-Big Island was awarded the Small Business of the Year award in September 2021 from the Bedford County Chamber of Commerce.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.50 contact hours, of which 1.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Phyllis Everett, MSN, RN, AOCN, AGN-BC, NP-C, have disclosed no relevant financial relationships.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
